	Impact of Distinct Molecular and Immunological Features of Breast Cancer on the Effectiveness of Therapies in Ghana. Breast Cancer (Auckl) Essilfie NK, Abakah A, Etsey M, Ofori-Amanfo D, Boampong K, Gyan BA, Kashala OL, Kwarteng EVS, Andam-Akorful SA, Paintsil V, Kwarteng A, Larbi AA. PMID: 42186480 [PubMed]
	Invasive lobular carcinoma: Shining a light on the second most prevalent type of breast cancer. Nurse Pract Csaky WL, Coombe AH, Kruse M. PMID: 42186108 [PubMed - indexed for MEDLINE]
	Leveraging the non-contrast CT component of PET/CT: an AI-driven delta-radiomics approach to monitor treatment response in metastatic breast cancer. BMC Med Imaging Kahraman EG, Unal OU, Taskaynatan H, Ozdemir O, Budak E, Selver MA. PMID: 42185986 [PubMed - as supplied by publisher]
	Effects of antenatal breast milk expression on maternal and infant outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth Cao Z, Huang M, Liu Y, Yin J, Zhao X. PMID: 42185981 [PubMed - as supplied by publisher]
	Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies. Breast Cancer Res Servitja S, Carrasco E, Andrés R, Rodríguez-Lescure Á, Martín M, Ruiz-Borrego M, Guerrero Á, Bermejo B, Antón A, Muñoz M, Margeli M, Álvarez I, Fernández LA, Ponce J, Cruz J, Martínez P, López-Tarruella S, Amenedo M, Blasco A, Polonio Ó, Gil-Gil M. PMID: 42185928 [PubMed - as supplied by publisher]
	Breast Arterial Calcification as a Predictor for Future Cardiovascular Events and Mortality: A Systematic Review and Meta-analysis. J Breast Imaging Nandurkar R, Vasanthakumar S, Stewart J, Aldous E, Tu H, Goel V, Scanlon L, Patel A, Soh C, Nerlekar N. PMID: 42185878 [PubMed - indexed for MEDLINE]
	Integrative co-delivery platforms for paclitaxel: Advancing synergistic breast cancer therapy. Biomed Pharmacother Almalki WH. PMID: 42184759 [PubMed - as supplied by publisher]
	Integrative multi-omics and network analysis identify potential targets of Chaihu Shugan Xiaozheng Formula in breast cancer. Transl Oncol Luo T, Xue M, Du Y, Chen H, Sun Y, Sun H. PMID: 42184719 [PubMed - as supplied by publisher]
	Can CCR2+ non-classical monocytes serve as a diagnostic biomarker in HER2-negative breast cancer? A pilot study. Cytokine Budzy, Kubicka A, Kycler W, Za, Brzezi, Grupi. PMID: 42184695 [PubMed - as supplied by publisher]
	A cross-sectional study on the expression of CD44 as a stem cell marker in breast cancer patients: Association with clinicopathological prognostic markers across molecular subtypes. Rev Esp Patol Krishnappa A, Kanakapura Paramesh H, Suresh R, Prashantha K, Vivek HK, Narasaraju TA. PMID: 42184620 [PubMed - as supplied by publisher]
	Challenges and outcomes of breast reconstruction in advanced-stage breast cancer: a comprehensive review. Cir Cir Barajas-Garcia MZ, Hernández-Sánchez EN, Ayala-Andrade MM, Bucheli-Villalobos A, Valdez-Perea DA, Espinoza-Ortiz LP, Jauregui-Gelviz AC, Galicia-Marín MA, Tiburcio-Jiménez D. PMID: 42184403 [PubMed - indexed for MEDLINE]
	Post-operative acute pain assessment and management in breast cancer patients: a best practice implementation project. JBI Evid Implement Zhong X, Tang H, Wu C, Zhang L, Chen W, Li Q, Ou Q, Xu H. PMID: 42184243 [PubMed - as supplied by publisher]
	An Adaptive Fusion Network for Breast Tumor Grading Based on Graph Structure Learning. IEEE J Biomed Health Inform Yang L, Li K, Yu Z, Jiang Y, Han S, Zhao X, Gao J, Jiang H, Ma L. PMID: 42184189 [PubMed - as supplied by publisher]
	Datopotamab deruxtecan for endocrine-resistant HR-positive/HER2-negative breast cancer: biological rationale and clinical evidence. Naunyn Schmiedebergs Arch Pharmacol Gumma B, Gumma L. PMID: 42183859 [PubMed - as supplied by publisher]
	Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy. J Radiat Res Sarsitthithum T, Nantavithya C, Lertbutsayanukul C, Saksornchai K. PMID: 42183732 [PubMed - as supplied by publisher]
	Breast Cancer Burden in BRICS Countries Attributable to Smoking, High Alcohol Use, High Body Mass Index, and Low Physical Activity, 1990-2021: Findings from the Global Burden of Disease 2021 and Mendelian Randomization. Int J Womens Health Yan X, Liao C, Qian S, Zhang C, Wu J, Fang J, Zhao X, Peng L. PMID: 42183404 [PubMed]
	Development and validation of a TLS-associated signature for prognosis prediction in breast cancer: new insights into QPRT. Front Immunol Li Q, Yang X, Wei L, Wang X, Wang X, Chen J, Zhao L, Wen S. PMID: 42183191 [PubMed - indexed for MEDLINE]
	Evaluation and Treatment Options for Abnormal Uterine Bleeding in Premenopausal Patients With a History of Breast Cancer. O G Open Nelis M, Chichura A. PMID: 42183172 [PubMed]
	Can cytology accurately predict the malignancy of feline mammary gland tumours? Vet Evid Virtanen J. PMID: 42183081 [PubMed]
	Recent advances in the delivery of natural-product antioxidants for the treatment of breast cancer. Front Bioeng Biotechnol Almansoori FE, Lee S. PMID: 42183061 [PubMed]

Articles 1 - 20 / 218066

Page 1 of 10904



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy